Comparative performances of enzyme-linked immunosorbent, Western blot, and polymerase chain reaction assays for human T-lymphotropic virus type II infection that is endemic among Indians of the Gran Chaco Region of South America

Transfusion

Volumn 37, Issue 1, 1997, Pages 52-59

  Poiesz, B J ^a   Dube, S ^b   Jones, B ^b   Bryz Gornia, V ^b   Dean, M T ^b   Spicer, T ^c   Hengst, J ^c   Sayre, K ^c   Esteban, E ^c   Ferrer, J F ^c  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b SUNY Health Science Center   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUMAN TISSUE; IMMUNOBLOTTING; INDIAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; SOUTH AMERICA; VIRUS DETECTION;

EID: 17344387468     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.37197176951.x     Document Type: Article

References (55)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980;77:7415-9.
2. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, et al. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982;218:571-3.
3. Watanabe T, Seiki M, Tsujimoto H, et al. Sequence homology of the simian retrovirus genome with human T-cell leukemia virus type-I. Virology 1985;144:59-65.
4. Goubau P, Van Brussel M, Vandamme A, et al. A primate T-lymphotropic virus, PTLV-L, different from human T-lymphotropic viruses types I and II, in a wild-caught baboon (Papio hamadryas). Proc Natl Acad Sci U S A 1994;91:2848-52.
5. Bhagavati S, Ehrlich G, Kula RW, et al. Detection of human T-cell lymphoma/leukemia virus type I DNA and antigen in spinal fluid and blood of patients with chronic progressive myelopathy. N Engl J Med 1988;318:1141-7.
6. Sherman MP, Amin RM, Rodgers-Johnson PE, et al. Identification of human T cell leukemia/lymphoma virus type I antibodies, DNA, and protein in patients with polymyositis. Arthritis Rheum 1995;38:690-8.
7. Mochizuki U, Watanabe T, Yamaguchi K, et al. Uveitis associated with human T lymphotropic virus type I: seroepidemiologic, clinical, and virologic studies (letter). J Infect Dis 1992;166:943-4.
8. Rosenblatt JD, Giorgi JV, Golde DW, et al. Integrated human T-cell leukemia virus II genome in CD8+ T cells from a patient with atypical hairy cell leukemia: evidence for distinct T and B cell lymphoproliferative disorders. Blood 1988;71:363-9.
9. Loughran TP Jr, Coyle T, Sherman MP, et al. Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia. Blood 1992;80:1116-9.
10. Hjelle B, Appenzeller O, Mills R, et al. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992;339:645-6.
11. Harrington WJ Jr, Sheremata W, Hjelle B, et al. Spastic ataxia associated with human T-cell lymphotropic virus type II infection. Ann Neurol 1993;33:411-4.
12. Poiesz BJ, Sherman M, Saksena N, et al. The biology and epidemiology of the human T-cell lymphoma/leukemia viruses. In: Neu HC, Levy J, Weiss R, eds. Frontiers of infectious diseases. Focus on HIV. London: Churchill Livingstone, 1993:189-205.
13. Seiki M, Hattori S, Hirayama Y, Yoshida M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci U S A 1983;80:3618-22.
14. Shimotohno K, Takahashi Y, Shimizu N, et al. Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene. Proc Natl Acad Sci U S A 1985;82:3101-5.
15. Hall WW, Takahashi H, Liu C, et al. Multiple isolates and characteristics of human T-cell leukemia virus type II. J Virol 1992;66:2456-63.
16. Dube DK, Dube S, Erensoy S, et al. Serological and nucleic acid analyses for HIV and HTLV infection on archival human plasma samples from Zaire. Virology 1994;202:379-89.
17. Dube DK, Sherman MP, Saksena NK, et al. Genetic heterogeneity in human T-cell leukemia/lymphoma virus type II. J Virol 1993;67:1175-84.
18. Ferrer JF, Del Pino N, Esteban E, et al. High rate of infection with the human T-cell leukemia retrovirus type II in four Indian populations of Argentina. Virology 1993;197:576-84.
19. Dube S, Spicer T, Bryz-Gornia V, et al. A rapid and sensitive method of identification of HTLV-II subtypes. J Med Virol 1995;45:1-9.
20. Ishak R, Harrington WJ Jr, Azevedo VN, et al. Identification of human T cell lymphotropic virus type IIA infection in the Kayapo, an indigenous population of Brazil. AIDS Res Hum Retroviruses 1995;11:813-21.
21. Williams AE, Fang CT, Slamon DJ, et al. Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors. Science 1988;240:643-6.
22. Anderson DW, Epstein JS, Lee TH, et al. Serological confirmation of human T-lymphotropic virus type I infection in healthy blood and plasma donors. Blood 1989;74:2585-91.
23. Horal P, Hall WW, Svennerholm B, et al. Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides. Proc Natl Acad Sci U S A 1991;88:5754-8.
24. Lipka JJ, Miyoshi I, Hadlock KG, et al. Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes. J Infect Dis 1992;165:268-72.
25. Ferrer JF, Esteban E, Dube S, et al. Endemic infection with human T-cell leukemia/lymphoma virus type IIB in Argentinian and Paraguayan Indians: epidemiology and molecular characterization. J Infect Dis 1996;174:944-53.
26. Kwok S, Kellogg D, Ehrlich G, et al. Characterization of a sequence of human T cell leukemia virus type I from a patient with chronic progressive myelopathy. J Infect Dis 1988;158:1193-7.
27. Dyster LM, Abbott L, Bryz-Gornia V, et al. Microplate-based DNA hybridization assays for detection of human retroviral gene sequences. J Clin Microbiol 1994;32:547-50.
28. Gossen C, Hagens S, Fukuchi R, et al. Comparison of six commercial human T-cell lymphotropic virus type I (HTLV-I) enzyme immunoassay kits for detection of antibody to HTLV-I and -II. J Clin Microbiol 1992;30:724-5.
29. Stock ND, Ferrer JF. Replicating C-type virus in phytohemagglutinin-treated buffy coat cultures of bovine origin. J Natl Cancer Inst 1972;48:985-96.
30. Iannone R, Sherman MP, Rodgers-Johnson PE, et al. HTLV-I DNA sequences in CNS tissue of a patient with tropical spastic paraparesis and HTLV-I-associated myelopathy. J Acquir Immune Defic Syndr 1992;5:810-6.
31. Abbott M, Poiesz BJ, Byrne BC, et al. Enzymatic gene amplification:qualitative and quantitative methods for detecting proviral DNA amplified in vitro. J Infect Dis 1988;158:1158-69.
32. Ehrlich GD, Davey FR, Kirshner JJ, et al. A polyclonal CD4+ and CD8+ lymphocytosis in a patient doubly infected with HTLV-I and HIV-1: a clinical and molecular analysis. Am J Hematol 1989;30:128-39.
33. Folks TM, Powell D, Lightfoote M, et al. Biological and biochemical characterization of a cloned Leu-3-cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med 1986;164:280-90.
34. Longo MC, Berninger MS, Hartley JL. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene 1990;93:125-8.
35. Abbott LZ, Spicer T, Bryz-Gornia V, et al. Design and use of signature primers to detect carryover of amplified material. J Virol Methods 1994;46:51-9.
36. Needleman SB, Wunsch CD. A general method applicable to the search for similarities in the amino acid sequence of two proteins. J Mol Biol 1970;48:443-53.
37. Swofford DL. "PAUP": phylogenetic analysis using parsimony," version 3.05. Distributed by the Illinois Natural History Survey, Champaign, IL, 1991.
38. Felsenstein J. PHILIP - pylogeny inference package. Cladistics 1989;5:164-6.
39. Guidelines for counseling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II). Ann Intern Med 1993;118:448-54.
40. Ehrlich GD, Glaser JB, Abbott MA, et al. Detection of anti-HTLV-I Tax antibodies in HTLV-I enzyme-linked immunosorbent assay-negative individuals. Blood 1989;74:1066-72.
41. Ehrlich GD, Glaser JB, LaVigne K, et al. Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction. Blood 1989;74:1658-64.
42. Kwok S, Lipka JJ, McKinney N, et al. Low incidence of HTLV infections in random blood donors with indeterminate western blot patterns. Transfusion 1990;30:491-4.
43. Wiktor SZ, Pate EJ, Weiss SH, et al. Sensitivity of HTLV-I antibody assays for HTLV-II (letter). Lancet 1991;338:512-3.
44. Palumbo PE, Weiss SH, McCreedy BJ, et al. Evaluation of human T cell lymphotropic virus infection in a cohort of injecting drug users. J Infect Dis 1992;166:896-9.
45. Aboulafia DM, Feigal E, Vranzian K, et al. Human T cell leukemia virus (HTLV-I/II) serodiagnostic testing: disparate results among a cohort of intravenous drug users. AIDS Res Hum Retroviruses 1993;9:1043-50.
46. Ishiguro N, Abe M, Seto K, et al. A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats. J Exp Med 1992;176:981-9.
47. Saksena N, Hervé V, Durand JP, et al. Seroepidemiologic, molecular, and phylogenetic analyses of simian T-cell leukemia viruses (STLV-I) from various naturally infected monkey species from central and western Africa. Virology 1994;198:297-310.
48. Kline RL, Vlahov D, Quinn TC. Improved detection of HTLV-II antibody using a whole viral lysate-based EIA (letter). J Acquir Immune Defic Syndr 1994;7:1291-2.
49. Hjelle B, Wilson C, Cyrus S, et al. Human T-cell leukemia virus type II infection frequently goes undetected in contemporary US blood donors. Blood 1993;81:1641-4.
50. Rios M, Khabbaz RF, Kaplan JE, et al. Transmission of human T cell lymphotropic virus (HTLV) type II by transfusion of HTLV-I-screened blood products. J Infect Dis 1994;170:206-10.
51. Esteban EN, Sherman MP, Poiesz BJ, et al. Transmission of human T-cell leukemia virus type I to sheep: antibody profile and detection of viral DNA sequences. AIDS Res Hum Retroviruses (in press).
52. Lal RB, Rudolph DL, Coligan JE, et al. Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II. Blood 1992;80:544-50.
53. Loughran TP Jr, Sherman MP, Ruscetti FW, et al. Prototypical HTLV-I/II infection is rare in LGL leukemia. Leuk Res 1994;18:423-9.
54. Gallo D, Diggs JL, Hanson CV. Evaluation of two commercial human T-cell lymphotropic virus western blot (immunoblot) kits with problem specimens. J Clin Microbiol 1994;32:2046-9.
55. Garin B, Gosselin S, de Thé G, Gessain A. HTLV-I/II infection in a high viral endemic area of Zaire, Central Africa: comparative evaluation of serology, PCR, and significance of indeterminate western blot pattern. J Med Virol 1994;44:104-9.